AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Kaltrax 100mg Injection

Prescription Icon
Prescription Required

Marketer

Kalmia Healthcare

Salt Composition

Tranexamic Acid (100mg)

Overview Kaltrax 100mg Injection

Tranexamic acid 100mg injection is indicated for hemorrhage management. It aids in preventing or lessening bleeding associated with dental extractions, menorrhagia, abnormal uterine bleeding, epistaxis, and procedures involving the oral cavity, prostate, or bladder. This antifibrinolytic medication functions by inhibiting clot dissolution, thus controlling bleeding. Administration should be strictly under medical supervision. Prior known hypersensitivity to this injection contraindicates its use. Commonly reported adverse effects include injection site reactions, fatigue, musculoskeletal discomfort, and nasal stuffiness. Disclosure of any prior cardiac surgery or existing kidney disease is crucial. This injection is considered safe for use during pregnancy and lactation, as well as in individuals with liver conditions.

Primary Ingredients of Kaltrax 100mg Injection

The provided text is "undefined," which lacks any meaning to rephrase. Therefore, no rewritten text can be provided.

Uses of Kaltrax 100mg Injection

Managing Hemorrhage

Major Benefits of Kaltrax 100mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Kaltrax 100mg Injection:

  • Joint pain
  • Headache
  • Back pain
  • Vomiting
  • Nausea
  • Abdominal pain
  • Diarrhea
  • Muscle cramp
  • Anemia (low number of red blood cells)
  • Lightheadedness

How to use Kaltrax 100mg Injection:

This medication will be administered by your physician or their qualified assistant. Self-medication is strongly discouraged.

How Kaltrax 100mg Injection works:

Hemostatic agent Kaltrax, administered via 100mg injection, inhibits fibrinolysis. This action safeguards against excessive blood loss, proving beneficial in managing menstrual bleeding and post-surgical hemorrhage.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Kaltrax 100mg Injection and alcohol can result in significant sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on Kaltrax 100mg Injection use in pregnancy is absent. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Kaltrax 100mg Injection while breastfeeding is likely inadvisable. Scant human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Kaltrax 100mg Injection on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Administering Kaltrax 100mg Injection requires careful consideration in individuals with impaired renal function. Dosage modification of Kaltrax 100mg Injection might be necessary. Physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

The use of Kaltrax 100mg Injection in individuals with liver impairment is likely safe. Current evidence indicates dose modification may not be necessary, though data is limited. Physician consultation is recommended.

What if you forget to take Kaltrax 100mg Injection :

Omit a Kaltrax 100mg Injection dose? Seek medical advice.

Facts to Know About Kaltrax 100mg Injection

LabelValue
Chemical Type Amino Acid and Peptide Analogs
Developing Habits No.
Treatment Category KINSHIP

FAQs on Kaltrax 100mg Injection

Kaltrax 100mg Injection must be administered intravenously via slow injection only. Intramuscular injection is contraindicated to avoid adverse reactions.
All medications carry potential side effects, though these are less likely if used as directed. The benefits usually outweigh the risks. However, Kaltrax 100mg Injection may rarely cause serious, potentially dangerous side effects such as anaphylaxis (rash, breathing difficulties, facial/oral/eyelid swelling), blood clots, or vision problems. Always consult your doctor before use and adhere strictly to prescribed instructions.
Kaltrax 100mg Injection helps stop bleeding by promoting blood clotting. Rarely, it may increase the risk of deep vein thrombosis (DVT), a blood clot in the leg. Studies suggest other factors may contribute to this risk, which appears higher in women using Kaltrax 100mg Injection. Always consult your doctor before use and follow their instructions carefully.
Prolonged Kaltrax 100mg Injection treatment may affect your color vision. Regular eye exams are therefore recommended, and any vision changes should be reported to your doctor immediately. They may discontinue the medication and prescribe an alternative if necessary.
Kaltrax 100mg Injection aids blood clotting but may, though rarely, cause life-threatening blood clots in the lungs (pulmonary embolism). While uncommon, pulmonary embolism risk increases with overdose, prolonged immobility, or pre-existing conditions. Other factors may also contribute to this increased risk.
Kaltrax 100mg Injection may be administered with or without food, and should be taken with water. Do not crush or chew the injection.
Dosage and treatment length for this medication vary depending on the condition. For heavy menstrual bleeding, a typical course is five days. Other conditions may require shorter or longer treatment periods, as determined by the doctor.
Kaltrax 100mg Injection does not impair fertility. Prescribed for heavy menstrual bleeding, it shows no evidence of disrupting ovulation. Consequently, it's not a contraceptive and won't affect your ability to conceive.
Kaltrax 100mg Injection can effectively stop nosebleeds by promoting blood clotting. For persistent nosebleeds, it may be used for up to a week.
Kaltrax 100mg Injection
100